Exact Mass: 410.3158

Exact Mass Matches: 410.3158

Found 81 metabolites which its exact mass value is equals to given mass value 410.3158, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

gamma-Tocotrienol

(2R)-3,4-Dihydro-2,7,8-trimethyl-2-[(3E,7E)-4,8,12-trimethyl-3,7,11-tridecatrien-1-yl]-2H-1-benzopyran-6-ol

C28H42O2 (410.3185)


gamma-Tocotrienol, also known as 7,8-dimethyltocotrienol, belongs to the class of organic compounds known as tocotrienols. These are vitamin E derivatives containing an unsaturated trimethyltrideca-3,7,11-trien-1-yl chain attached to the C6 atom of a benzopyran ring system. They differ from tocopherols that contain a saturated trimethyltridecyl chain. Thus, gamma-tocotrienol is considered to be a quinone lipid molecule. gamma-Tocotrienol is a very hydrophobic molecule, practically insoluble (in water), and relatively neutral. gamma-Tocotrienol targets cancer cells by inhibiting Id1, a key cancer-promoting protein. gamma-Tocotrienol was shown to trigger cell apoptosis and well as anti-proliferation of cancer cells. This mechanism was also observed in separate prostate cancer and melanoma cell line studies. Constituent of palm oil. Nutriceutical with anticancer props. and a positive influence on the blood lipid profile. gamma-Tocotrienol is found in many foods, some of which are rye, corn, rosemary, and common grape. Acquisition and generation of the data is financially supported in part by CREST/JST. γ-Tocotrienol is an active form of vitamin E. γ-tocotrienol reverses the multidrug resistance (MDR) of breast cancer cells through the signaling pathway of NF-κB and P-gp. γ-Tocotrienol is also a novel radioprotector agent, can mitigate bone marrow radiation damage during targeted radionuclide treatment[1][2][3]. γ-Tocotrienol is an active form of vitamin E. γ-tocotrienol reverses the multidrug resistance (MDR) of breast cancer cells through the signaling pathway of NF-κB and P-gp. γ-Tocotrienol is also a novel radioprotector agent, can mitigate bone marrow radiation damage during targeted radionuclide treatment[1][2][3].

   

beta-tocotrienol

(2R)-2,5,8-Trimethyl-2-[(3E,7E)-4,8,12-trimethyltrideca-3,7,11-trien-1-yl]-3,4-dihydro-2H-1-benzopyran-6-ol

C28H42O2 (410.3185)


   

2,3-dimethyl-6-geranylgeranyl-1,4-benzoquinol

2,3-dimethyl-6-geranylgeranyl-1,4-benzoquinol

C28H42O2 (410.3185)


   

epsilon-Tocopherol

(2R)-3,4-dihydro-2,5,8-trimethyl-2-[(3E,7E)-4,8,12-trimethyl-3,7,11-tridecatrienyl]-2H-1-benzopyran-6-ol

C28H42O2 (410.3185)


Isolated from wheat bran oil. epsilon-Tocopherol is found in many foods, some of which are rye, coconut, rosemary, and fennel. epsilon-Tocopherol is found in american cranberry. epsilon-Tocopherol is isolated from wheat bran oi

   

(3beta,22E,24R)-3-Hydroxyergosta-5,8,22-trien-7-one

14-[(3E)-5,6-dimethylhept-3-en-2-yl]-5-hydroxy-2,15-dimethyltetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadeca-1(10),7-dien-9-one

C28H42O2 (410.3185)


(3beta,22E,24R)-3-Hydroxyergosta-5,8,22-trien-7-one is found in mushrooms. (3beta,22E,24R)-3-Hydroxyergosta-5,8,22-trien-7-one is a constituent of Grifola frondosa (maitake) Constituent of Grifola frondosa (maitake). (3beta,22E,24R)-3-Hydroxyergosta-5,8,22-trien-7-one is found in mushrooms.

   

(6alpha,22E)-6-Hydroxy-4,7,22-ergostatrien-3-one

14-[(3E)-5,6-dimethylhept-3-en-2-yl]-8-hydroxy-2,15-dimethyltetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadeca-6,9-dien-5-one

C28H42O2 (410.3185)


(6beta,22E)-6-Hydroxy-4,7,22-ergostatrien-3-one is found in mushrooms. (6beta,22E)-6-Hydroxy-4,7,22-ergostatrien-3-one is a metabolite of Ganoderma lucidum (reishi).

   

N-Oleoyl Glutamine

4-(C-Hydroxycarbonimidoyl)-2-[(1-hydroxyoctadec-9-en-1-ylidene)amino]butanoate

C23H42N2O4 (410.3144)


N-oleoyl glutamine belongs to the class of compounds known as N-acylamides. These are molecules characterized by a fatty acyl group linked to a primary amine by an amide bond. More specifically, it is an Oleic acid amide of Glutamine. It is believed that there are more than 800 types of N-acylamides in the human body. N-acylamides fall into several categories: amino acid conjugates (e.g., those acyl amides conjugated with amino acids), neurotransmitter conjugates (e.g., those acylamides conjugated with neurotransmitters), ethanolamine conjugates (e.g., those acylamides conjugated to ethanolamine), and taurine conjugates (e.g., those acyamides conjugated to taurine). N-Oleoyl Glutamine is an amino acid conjugate. N-acylamides can be classified into 9 different categories depending on the size of their acyl-group: 1) short-chain N-acylamides; 2) medium-chain N-acylamides; 3) long-chain N-acylamides; and 4) very long-chain N-acylamides; 5) hydroxy N-acylamides; 6) branched chain N-acylamides; 7) unsaturated N-acylamides; 8) dicarboxylic N-acylamides and 9) miscellaneous N-acylamides. N-Oleoyl Glutamine is therefore classified as a long chain N-acylamide. N-acyl amides have a variety of signaling functions in physiology, including in cardiovascular activity, metabolic homeostasis, memory, cognition, pain, motor control and others (PMID: 15655504). N-acyl amides have also been shown to play a role in cell migration, inflammation and certain pathological conditions such as diabetes, cancer, neurodegenerative disease, and obesity (PMID: 23144998; PMID: 25136293; PMID: 28854168).N-acyl amides can be synthesized both endogenously and by gut microbiota (PMID: 28854168). N-acylamides can be biosynthesized via different routes, depending on the parent amine group. N-acyl ethanolamines (NAEs) are formed via the hydrolysis of an unusual phospholipid precursor, N-acyl-phosphatidylethanolamine (NAPE), by a specific phospholipase D. N-acyl amino acids are synthesized via a circulating peptidase M20 domain containing 1 (PM20D1), which can catalyze the bidirectional the condensation and hydrolysis of a variety of N-acyl amino acids. The degradation of N-acylamides is largely mediated by an enzyme called fatty acid amide hydrolase (FAAH), which catalyzes the hydrolysis of N-acylamides into fatty acids and the biogenic amines. Many N-acylamides are involved in lipid signaling system through interactions with transient receptor potential channels (TRP). TRP channel proteins interact with N-acyl amides such as N-arachidonoyl ethanolamide (Anandamide), N-arachidonoyl dopamine and others in an opportunistic fashion (PMID: 23178153). This signaling system has been shown to play a role in the physiological processes involved in inflammation (PMID: 25136293). Other N-acyl amides, including N-oleoyl-glutamine, have also been characterized as TRP channel antagonists (PMID: 29967167). N-acylamides have also been shown to have G-protein-coupled receptors (GPCRs) binding activity (PMID: 28854168). The study of N-acylamides is an active area of research and it is likely that many novel N-acylamides will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered for these molecules.

   

(2R)-2,5,8-Trimethyl-2-(4,8,12-trimethyltrideca-3,7,11-trienyl)-3,4-dihydrochromen-6-ol

2,5,8-trimethyl-2-(4,8,12-trimethyltrideca-3,7,11-trien-1-yl)-3,4-dihydro-2H-1-benzopyran-6-ol

C28H42O2 (410.3185)


   

(2R)-2,7,8-Trimethyl-2-(4,8,12-trimethyltrideca-3,7,11-trienyl)-3,4-dihydrochromen-6-ol

2,7,8-trimethyl-2-(4,8,12-trimethyltrideca-3,7,11-trien-1-yl)-3,4-dihydro-2H-1-benzopyran-6-ol

C28H42O2 (410.3185)


   

2-Pyridinemethanamine, N-((4-(1,4,8,11-tetraazacyclotetradec-1-ylmethyl)phenyl)methyl)-

[(pyridin-2-yl)methyl]({4-[(1,4,8,11-tetraazacyclotetradecan-1-yl)methyl]phenyl}methyl)amine

C24H38N6 (410.3158)


   

Topsentisterol E1

Topsentisterol E1

C28H42O2 (410.3185)


   

9(11)-dehydroergosterol peroxide

9(11)-dehydroergosterol peroxide

C28H42O2 (410.3185)


   

parvifoliol E

parvifoliol E

C28H42O2 (410.3185)


   
   

(6beta,22E)-6-Hydroxy-4,7,22-ergostatrien-3-one

(6beta,22E)-6-Hydroxy-4,7,22-ergostatrien-3-one

C28H42O2 (410.3185)


   

Lolanoquinon|Solanoquinone

Lolanoquinon|Solanoquinone

C28H42O2 (410.3185)


   

24-exomethylenecalicoferol E|24-exomethylenwcalicoferol E|24-methylenecalicoferol E

24-exomethylenecalicoferol E|24-exomethylenwcalicoferol E|24-methylenecalicoferol E

C28H42O2 (410.3185)


   

calicoferol D

(22E)-(8S)-3-hydroxy-22-methyl-9,10-seco-1,3,5(10),22-cholestatetraen-9-one

C28H42O2 (410.3185)


   

4,7,10,13,16,19,22-octacosaheptaenoic acid

4,7,10,13,16,19,22-octacosaheptaenoic acid

C28H42O2 (410.3185)


   

cyathisterol

cyathisterol

C28H42O2 (410.3185)


   

(20S)-20-hydroxyergosta-1,4,24(28)-trien-3-one|methyl (20S)-20-hydroxyergosta-1,4,24(28)-trien-3-one

(20S)-20-hydroxyergosta-1,4,24(28)-trien-3-one|methyl (20S)-20-hydroxyergosta-1,4,24(28)-trien-3-one

C28H42O2 (410.3185)


   

(24R)-24-methylcholesta-4,22E-dien-3,6-dione

(24R)-24-methylcholesta-4,22E-dien-3,6-dione

C28H42O2 (410.3185)


   

(22E,24R)-ergosta-7,22-dien-3,6-dione|(22E,24R)-ergosta-7,22-diene-3,6-dione|cyathisterone

(22E,24R)-ergosta-7,22-dien-3,6-dione|(22E,24R)-ergosta-7,22-diene-3,6-dione|cyathisterone

C28H42O2 (410.3185)


   

gamma-Tocotrienol

2,7,8-TRIMETHYL-2-[(3E,7E,11E,15E,19E,23E,27E)-4,8,12,16,20,24,28,32-O CTAMETHYL-3,7,11,15,19,23,27,31-TRITRIACONTAOCTAENYL]-6-CHROMANOL

C28H42O2 (410.3185)


gamma-Tocotrienol, also known as 7,8-dimethyltocotrienol, belongs to the class of organic compounds known as tocotrienols. These are vitamin E derivatives containing an unsaturated trimethyltrideca-3,7,11-trien-1-yl chain attached to the C6 atom of a benzopyran ring system. They differ from tocopherols that contain a saturated trimethyltridecyl chain. Thus, gamma-tocotrienol is considered to be a quinone lipid molecule. gamma-Tocotrienol is a very hydrophobic molecule, practically insoluble (in water), and relatively neutral. gamma-Tocotrienol targets cancer cells by inhibiting Id1, a key cancer-promoting protein. gamma-Tocotrienol was shown to trigger cell apoptosis and well as anti-proliferation of cancer cells. This mechanism was also observed in separate prostate cancer and melanoma cell line studies. Gamma-tocotrienol is a tocotrienol that is chroman-6-ol substituted by methyl groups at positions 2, 7 and 8 and a farnesyl chain at position 2. A vitamin E family member that has potent anti-cancer properties against a wide-range of cancers. It has a role as an antioxidant, an antineoplastic agent, a plant metabolite, a radiation protective agent, an apoptosis inducer and a hepatoprotective agent. It is a tocotrienol and a vitamin E. gamma-Tocotrienol is a natural product found in Amaranthus cruentus, Triadica sebifera, and other organisms with data available. A tocotrienol that is chroman-6-ol substituted by methyl groups at positions 2, 7 and 8 and a farnesyl chain at position 2. A vitamin E family member that has potent anti-cancer properties against a wide-range of cancers. Constituent of palm oil. Nutriceutical with anticancer props. and a positive influence on the blood lipid profile. gamma-Tocotrienol is found in many foods, some of which are rye, corn, rosemary, and common grape. γ-Tocotrienol is an active form of vitamin E. γ-tocotrienol reverses the multidrug resistance (MDR) of breast cancer cells through the signaling pathway of NF-κB and P-gp. γ-Tocotrienol is also a novel radioprotector agent, can mitigate bone marrow radiation damage during targeted radionuclide treatment[1][2][3]. γ-Tocotrienol is an active form of vitamin E. γ-tocotrienol reverses the multidrug resistance (MDR) of breast cancer cells through the signaling pathway of NF-κB and P-gp. γ-Tocotrienol is also a novel radioprotector agent, can mitigate bone marrow radiation damage during targeted radionuclide treatment[1][2][3].

   

γ-Tocotrienol

gamma-Tocotrienol

C28H42O2 (410.3185)


γ-Tocotrienol is an active form of vitamin E. γ-tocotrienol reverses the multidrug resistance (MDR) of breast cancer cells through the signaling pathway of NF-κB and P-gp. γ-Tocotrienol is also a novel radioprotector agent, can mitigate bone marrow radiation damage during targeted radionuclide treatment[1][2][3]. γ-Tocotrienol is an active form of vitamin E. γ-tocotrienol reverses the multidrug resistance (MDR) of breast cancer cells through the signaling pathway of NF-κB and P-gp. γ-Tocotrienol is also a novel radioprotector agent, can mitigate bone marrow radiation damage during targeted radionuclide treatment[1][2][3].

   

2,2,6,6-Tetra-tert-butyl-4,4-biphenol

3,3,5,5-Tetra-tert-butyl-4,4-dihydroxybiphenyl

C28H42O2 (410.3185)


   

N-oleoyl glutamine

N-(9Z-octadecenoyl)-glutamine

C23H42N2O4 (410.3144)


   

3beta-Hydroxy-(22E,24R)-ergosta-5,8,22-trien-7-one

14-[(3E)-5,6-dimethylhept-3-en-2-yl]-5-hydroxy-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-1(10),7-dien-9-one

C28H42O2 (410.3185)


   

(6alpha,22E)-6-Hydroxy-4,7,22-ergostatrien-3-one

14-[(3E)-5,6-dimethylhept-3-en-2-yl]-8-hydroxy-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-6,9-dien-5-one

C28H42O2 (410.3185)


   

28:7(n-6)

4Z,7Z,10Z,13Z,16Z,19Z,22Z-octacosaheptaenoic acid

C28H42O2 (410.3185)


   

FA 28:7

4Z,7Z,10Z,13Z,16Z,19Z,22Z-octacosaheptaenoic acid

C28H42O2 (410.3185)


   

ST 28:4;O2

12alpha-hydroxyergosta-7,22,24(28)-triene-3-one

C28H42O2 (410.3185)


   

boc-d-cyclopropylalanine-dcha

boc-d-cyclopropylalanine-dcha

C23H42N2O4 (410.3144)


   

3,3,5,5-Tetra-tert-butyl-2,2-biphenyldiol

3,3,5,5-Tetra-tert-butyl-2,2-biphenyldiol

C28H42O2 (410.3185)


   

Pyridinium,1-[[(1-oxooctadecyl)amino]methyl]-, chloride (1:1)

Pyridinium,1-[[(1-oxooctadecyl)amino]methyl]-, chloride (1:1)

C24H43ClN2O (410.3064)


   

boc-4,5-dehydro-leu-oh dcha

boc-4,5-dehydro-leu-oh dcha

C23H42N2O4 (410.3144)


   

phenyl acetaldehyde digeranyl acetal

phenyl acetaldehyde digeranyl acetal

C28H42O2 (410.3185)


   

1-Naphthyl stearate

1-Naphthyl stearate

C28H42O2 (410.3185)


   

Octadecanoic acid,2-naphthalenyl ester

Octadecanoic acid,2-naphthalenyl ester

C28H42O2 (410.3185)


   

Boc-L-Cyclopropylalanine-DCHA

Boc-L-Cyclopropylalanine-DCHA

C23H42N2O4 (410.3144)


   

CHEBI:33277

2H-1-Benzopyran-6-ol, 3,4-dihydro-2,7,8-trimethyl-2-[(3E,7E)-4,8,12-trimethyl-3,7,11-tridecatrienyl]-, (2R)- (9CI)

C28H42O2 (410.3185)


γ-Tocotrienol is an active form of vitamin E. γ-tocotrienol reverses the multidrug resistance (MDR) of breast cancer cells through the signaling pathway of NF-κB and P-gp. γ-Tocotrienol is also a novel radioprotector agent, can mitigate bone marrow radiation damage during targeted radionuclide treatment[1][2][3]. γ-Tocotrienol is an active form of vitamin E. γ-tocotrienol reverses the multidrug resistance (MDR) of breast cancer cells through the signaling pathway of NF-κB and P-gp. γ-Tocotrienol is also a novel radioprotector agent, can mitigate bone marrow radiation damage during targeted radionuclide treatment[1][2][3].

   

(2R)-2,7,8-Trimethyl-2-(4,8,12-trimethyltrideca-3,7,11-trienyl)-3,4-dihydrochromen-6-ol

2,7,8-trimethyl-2-(4,8,12-trimethyltrideca-3,7,11-trien-1-yl)-3,4-dihydro-2H-1-benzopyran-6-ol

C28H42O2 (410.3185)


   

3,4-Dihydro-2,7,8-trimethyl-2-[(3E,7E)-4,8,12-trimethyl-3,7,11-tridecatrienyl]-2H-1-benzopyran-6-ol

3,4-Dihydro-2,7,8-trimethyl-2-[(3E,7E)-4,8,12-trimethyl-3,7,11-tridecatrienyl]-2H-1-benzopyran-6-ol

C28H42O2 (410.3185)


   

5-amino-2-[[(E)-octadec-9-enoyl]amino]-5-oxopentanoic acid

5-amino-2-[[(E)-octadec-9-enoyl]amino]-5-oxopentanoic acid

C23H42N2O4 (410.3144)


   

(22E,24R)-ergosta-7,22-diene-3,6-dione

(22E,24R)-ergosta-7,22-diene-3,6-dione

C28H42O2 (410.3185)


A 3-oxo Delta(7)-steroid that is (22E)-ergosta-7,22-diene substituted by oxo groups at positions 3 and 6. It has been isolated from Penicillium commune.

   

(7Z,10Z,13Z,16Z,19Z,22Z,25Z)-octacosa-7,10,13,16,19,22,25-heptaenoic acid

(7Z,10Z,13Z,16Z,19Z,22Z,25Z)-octacosa-7,10,13,16,19,22,25-heptaenoic acid

C28H42O2 (410.3185)


   

e-Tokoferol

(2R)-3,4-dihydro-2,5,8-trimethyl-2-[(3E,7E)-4,8,12-trimethyl-3,7,11-tridecatrienyl]-2H-1-benzopyran-6-ol

C28H42O2 (410.3185)


A tocotrienol that is chroman-6-ol substituted by methyl groups at positions 2, 5 and 8 and a farnesyl chain at position 2. It has been isolated from various cultivars of wheat.

   

(3beta,22E,24R)-3-Hydroxyergosta-5,8,22-trien-7-one

(3beta,22E,24R)-3-Hydroxyergosta-5,8,22-trien-7-one

C28H42O2 (410.3185)


   

Gama-Tocotrienol

Gama-Tocotrienol

C28H42O2 (410.3185)


   

4Z,7Z,10Z,13Z,16Z,19Z,22Z-octacosaheptaenoic acid

4Z,7Z,10Z,13Z,16Z,19Z,22Z-octacosaheptaenoic acid

C28H42O2 (410.3185)


   

Octacosaheptaenoic acid

Octacosaheptaenoic acid

C28H42O2 (410.3185)


   

NA-Arg 17:1(9Z)

NA-Arg 17:1(9Z)

C22H42N4O3 (410.3257)


   

NA-Asn 19:1(9Z)

NA-Asn 19:1(9Z)

C23H42N2O4 (410.3144)


   

NA-Gln 18:1(9Z)

NA-Gln 18:1(9Z)

C23H42N2O4 (410.3144)


   

(1s,3as,3bs,9ar,9bs,11as)-1-[(2s)-2-hydroxy-6-methyl-5-methylideneheptan-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,5h,9bh,10h,11h-cyclopenta[a]phenanthren-7-one

(1s,3as,3bs,9ar,9bs,11as)-1-[(2s)-2-hydroxy-6-methyl-5-methylideneheptan-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,5h,9bh,10h,11h-cyclopenta[a]phenanthren-7-one

C28H42O2 (410.3185)


   

(2s)-6-methoxy-2,8-dimethyl-2-[(3e,7e)-4,8,12-trimethyltrideca-3,7,11-trien-1-yl]-3,4-dihydro-1-benzopyran

(2s)-6-methoxy-2,8-dimethyl-2-[(3e,7e)-4,8,12-trimethyltrideca-3,7,11-trien-1-yl]-3,4-dihydro-1-benzopyran

C28H42O2 (410.3185)


   

(1r,7s,9as,11ar)-1-[(2r,3e,5r)-5,6-dimethylhept-3-en-2-yl]-7-hydroxy-9a,11a-dimethyl-1h,2h,3h,3ah,6h,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-4-one

(1r,7s,9as,11ar)-1-[(2r,3e,5r)-5,6-dimethylhept-3-en-2-yl]-7-hydroxy-9a,11a-dimethyl-1h,2h,3h,3ah,6h,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-4-one

C28H42O2 (410.3185)


   

(1r,3ar,3br,9ar,9br,11ar)-1-[(2r,3e,5r)-5,6-dimethylhept-3-en-2-yl]-3b-hydroxy-9a,11a-dimethyl-1h,2h,3h,3ah,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-one

(1r,3ar,3br,9ar,9br,11ar)-1-[(2r,3e,5r)-5,6-dimethylhept-3-en-2-yl]-3b-hydroxy-9a,11a-dimethyl-1h,2h,3h,3ah,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-one

C28H42O2 (410.3185)


   

6β-hydroxyergosta-4,7,22-trien-3-one

NA

C28H42O2 (410.3185)


{"Ingredient_id": "HBIN012274","Ingredient_name": "6\u03b2-hydroxyergosta-4,7,22-trien-3-one","Alias": "NA","Ingredient_formula": "C28H42O2","Ingredient_Smile": "NA","Ingredient_weight": "410.63","OB_score": "25.38516555","CAS_id": "68378-35-8","SymMap_id": "SMIT12077","TCMID_id": "NA","TCMSP_id": "MOL011142","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

(9ar,11ar)-1-[(2r,3e,5r)-5,6-dimethylhept-3-en-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,5ah,6h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthrene-5,7-dione

(9ar,11ar)-1-[(2r,3e,5r)-5,6-dimethylhept-3-en-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,5ah,6h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthrene-5,7-dione

C28H42O2 (410.3185)


   

(1r,3ar,7s,9as,11ar)-1-[(2r,3e,5s)-5,6-dimethylhept-3-en-2-yl]-7-hydroxy-9a,11a-dimethyl-1h,2h,3h,3ah,6h,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-4-one

(1r,3ar,7s,9as,11ar)-1-[(2r,3e,5s)-5,6-dimethylhept-3-en-2-yl]-7-hydroxy-9a,11a-dimethyl-1h,2h,3h,3ah,6h,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-4-one

C28H42O2 (410.3185)


   

1-(2-hydroxy-6-methyl-5-methylideneheptan-2-yl)-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,5h,9bh,10h,11h-cyclopenta[a]phenanthren-7-one

1-(2-hydroxy-6-methyl-5-methylideneheptan-2-yl)-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,5h,9bh,10h,11h-cyclopenta[a]phenanthren-7-one

C28H42O2 (410.3185)


   

(3r,3ar,5r,8s,11br)-3-[(2s,3e,5s)-5,6-dimethylhept-3-en-2-yl]-3a,6-dimethyl-1h,2h,3h,4h,5h,7h,8h,9h,10h,11bh-cyclopenta[a]anthracene-5,8-diol

(3r,3ar,5r,8s,11br)-3-[(2s,3e,5s)-5,6-dimethylhept-3-en-2-yl]-3a,6-dimethyl-1h,2h,3h,4h,5h,7h,8h,9h,10h,11bh-cyclopenta[a]anthracene-5,8-diol

C28H42O2 (410.3185)


   

(1r,3ar,7s,9as,11ar)-1-[(2r,3e,5r)-5,6-dimethylhept-3-en-2-yl]-7-hydroxy-9a,11a-dimethyl-1h,2h,3h,3ah,6h,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-4-one

(1r,3ar,7s,9as,11ar)-1-[(2r,3e,5r)-5,6-dimethylhept-3-en-2-yl]-7-hydroxy-9a,11a-dimethyl-1h,2h,3h,3ah,6h,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-4-one

C28H42O2 (410.3185)


   

(1r,3ar,7s,9as,11ar)-1-[(2r,3e,5r)-5,6-dimethylhept-3-en-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,6h,7h,8h,9h,11h-cyclopenta[a]phenanthrene-7-peroxol

(1r,3ar,7s,9as,11ar)-1-[(2r,3e,5r)-5,6-dimethylhept-3-en-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,6h,7h,8h,9h,11h-cyclopenta[a]phenanthrene-7-peroxol

C28H42O2 (410.3185)


   

1-(5,6-dimethylhept-3-en-2-yl)-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthrene-5,7-dione

1-(5,6-dimethylhept-3-en-2-yl)-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthrene-5,7-dione

C28H42O2 (410.3185)


   

(2s)-6-methoxy-2,8-dimethyl-2-(4,8,12-trimethyltrideca-3,7,11-trien-1-yl)-3,4-dihydro-1-benzopyran

(2s)-6-methoxy-2,8-dimethyl-2-(4,8,12-trimethyltrideca-3,7,11-trien-1-yl)-3,4-dihydro-1-benzopyran

C28H42O2 (410.3185)


   

(2s)-2,6,7-trimethyl-2-[(3e,7e)-4,8,12-trimethyltrideca-3,7,11-trien-1-yl]-3,4-dihydro-1-benzopyran-8-ol

(2s)-2,6,7-trimethyl-2-[(3e,7e)-4,8,12-trimethyltrideca-3,7,11-trien-1-yl]-3,4-dihydro-1-benzopyran-8-ol

C28H42O2 (410.3185)


   

octacosa-4,7,10,13,16,19,22-heptaenoic acid

octacosa-4,7,10,13,16,19,22-heptaenoic acid

C28H42O2 (410.3185)


   

(1r,5ar,7s,9as,11ar)-7-hydroxy-9a,11a-dimethyl-1-[(2r)-6-methyl-5-methylideneheptan-2-yl]-1h,2h,5h,5ah,6h,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-4-one

(1r,5ar,7s,9as,11ar)-7-hydroxy-9a,11a-dimethyl-1-[(2r)-6-methyl-5-methylideneheptan-2-yl]-1h,2h,5h,5ah,6h,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-4-one

C28H42O2 (410.3185)


   

1-(5,6-dimethylhept-3-en-2-yl)-9a,11a-dimethyl-1h,2h,3h,3ah,6h,7h,8h,9h,11h-cyclopenta[a]phenanthrene-7-peroxol

1-(5,6-dimethylhept-3-en-2-yl)-9a,11a-dimethyl-1h,2h,3h,3ah,6h,7h,8h,9h,11h-cyclopenta[a]phenanthrene-7-peroxol

C28H42O2 (410.3185)


   

(1s,2s,5r,6r,9s,10s,15s,19s)-5-methyl-6-[(2r)-6-methyl-5-methylideneheptan-2-yl]-16-oxapentacyclo[13.2.2.0¹,¹³.0²,¹⁰.0⁵,⁹]nonadeca-11,13-dien-19-ol

(1s,2s,5r,6r,9s,10s,15s,19s)-5-methyl-6-[(2r)-6-methyl-5-methylideneheptan-2-yl]-16-oxapentacyclo[13.2.2.0¹,¹³.0²,¹⁰.0⁵,⁹]nonadeca-11,13-dien-19-ol

C28H42O2 (410.3185)


   

1-(5,6-dimethylhept-3-en-2-yl)-9a,11a-dimethyl-1h,2h,3h,3ah,5ah,6h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthrene-5,7-dione

1-(5,6-dimethylhept-3-en-2-yl)-9a,11a-dimethyl-1h,2h,3h,3ah,5ah,6h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthrene-5,7-dione

C28H42O2 (410.3185)


   

(1r,3ar,7s,9as,11ar)-1-[(2s,3e,5s)-5,6-dimethylhept-3-en-2-yl]-7-hydroxy-9a,11a-dimethyl-1h,2h,3h,3ah,6h,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-4-one

(1r,3ar,7s,9as,11ar)-1-[(2s,3e,5s)-5,6-dimethylhept-3-en-2-yl]-7-hydroxy-9a,11a-dimethyl-1h,2h,3h,3ah,6h,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-4-one

C28H42O2 (410.3185)


   

(1r,3as,3bs,9ar,9bs,11ar)-1-[(2r,3e,5r)-5,6-dimethylhept-3-en-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthrene-5,7-dione

(1r,3as,3bs,9ar,9bs,11ar)-1-[(2r,3e,5r)-5,6-dimethylhept-3-en-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthrene-5,7-dione

C28H42O2 (410.3185)


   

2,6,7-trimethyl-2-(4,8,12-trimethyltrideca-3,7,11-trien-1-yl)-3,4-dihydro-1-benzopyran-8-ol

2,6,7-trimethyl-2-(4,8,12-trimethyltrideca-3,7,11-trien-1-yl)-3,4-dihydro-1-benzopyran-8-ol

C28H42O2 (410.3185)


   

(1r,3ar,5as,9ar,9br,11ar)-1-[(2r,3e,5r)-5,6-dimethylhept-3-en-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,5ah,6h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthrene-5,7-dione

(1r,3ar,5as,9ar,9br,11ar)-1-[(2r,3e,5r)-5,6-dimethylhept-3-en-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,5ah,6h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthrene-5,7-dione

C28H42O2 (410.3185)


   

1-(5,6-dimethylhept-3-en-2-yl)-7-hydroxy-9a,11a-dimethyl-1h,2h,3h,3ah,6h,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-4-one

1-(5,6-dimethylhept-3-en-2-yl)-7-hydroxy-9a,11a-dimethyl-1h,2h,3h,3ah,6h,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-4-one

C28H42O2 (410.3185)


   

(4e,7e,10e,13e,16e,19e,22e)-octacosa-4,7,10,13,16,19,22-heptaenoic acid

(4e,7e,10e,13e,16e,19e,22e)-octacosa-4,7,10,13,16,19,22-heptaenoic acid

C28H42O2 (410.3185)


   

1-(5,6-dimethylhept-3-en-2-yl)-3b-hydroxy-9a,11a-dimethyl-1h,2h,3h,3ah,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-one

1-(5,6-dimethylhept-3-en-2-yl)-3b-hydroxy-9a,11a-dimethyl-1h,2h,3h,3ah,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-one

C28H42O2 (410.3185)